LeadIQ logo
Learn more at LeadIQ.com

Insights

Precision Genetic Medicines Code Bio focuses on delivering precision genetic medicines using its proprietary 3DNA® delivery platform. This innovative approach differentiates the company in the biotechnology research industry, presenting a sales opportunity to promote targeted therapies with reduced side effects.

Disease Focus Expansion With research programs targeting the lungs, pancreas, and liver in addition to Duchenne's Muscular Dystrophy (DMD), Code Bio is diversifying its disease focus. Sales development representatives can explore partnerships for addressing multiple health areas, potentially broadening the customer base.

Competitive Positioning Comparing employee size and revenue to similar companies like Sarepta Therapeutics and Moderna, Code Bio's smaller scale presents an advantage in agility and personalized service. This selling point can appeal to clients seeking tailored solutions and closer engagement with the research team.

Funding Validation Having secured $75 million in funding, Code Bio demonstrates financial stability and investor confidence in its vision. This financial backing enhances the company's credibility, providing a strong sales proposition to potential partners and collaborators looking for long-term commitments.

Strategic Market Positioning Code Bio's technology stack includes Google Cloud and Google Analytics, indicating a strategic focus on data analytics and cloud-based solutions. This technological alignment positions the company well in the market for engaging with tech-savvy clients seeking advanced biotech solutions.

Similar companies to Code Biotherapeutics

Code Biotherapeutics Tech Stack

Code Biotherapeutics uses 8 technology products and services including Google Analytics Enhanced eCommerce, Wix, Cart Functionality, and more. Explore Code Biotherapeutics's tech stack below.

  • Google Analytics Enhanced eCommerce
    Analytics
  • Wix
    Content Management System
  • Cart Functionality
    E-commerce
  • Microsoft PowerPoint
    Editors
  • Google Cloud
    Infrastructure As A Service
  • Lodash
    Javascript Libraries
  • reCAPTCHA
    Security
  • Minitab
    Visualisation Software

Media & News

Code Biotherapeutics's Email Address Formats

Code Biotherapeutics uses at least 1 format(s):
Code Biotherapeutics Email FormatsExamplePercentage
FLast@codebiotx.comJDoe@codebiotx.com
49%
FL@codebiotx.comJD@codebiotx.com
1%
FirstLast@codebiotx.comJohnDoe@codebiotx.com
1%
FLast@codebiotx.comJDoe@codebiotx.com
49%

Frequently Asked Questions

Where is Code Biotherapeutics's headquarters located?

Minus sign iconPlus sign icon
Code Biotherapeutics's main headquarters is located at 2801 Sterling Dr Hatfield, Pennsylvania 19440 US. The company has employees across 1 continents, including North America.

What is Code Biotherapeutics's official website and social media links?

Minus sign iconPlus sign icon
Code Biotherapeutics's official website is codebiotx.com and has social profiles on LinkedIn.

How much revenue does Code Biotherapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Code Biotherapeutics's annual revenue reached $1.8M.

What is Code Biotherapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Code Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Code Biotherapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Code Biotherapeutics has approximately 33 employees across 1 continents, including North America. Key team members include Chief Technical Officer: A. T.Chief Financial Officer: K. D.Chief Scientific Officer: D. A.. Explore Code Biotherapeutics's employee directory with LeadIQ.

What industry does Code Biotherapeutics belong to?

Minus sign iconPlus sign icon
Code Biotherapeutics operates in the Biotechnology Research industry.

What technology does Code Biotherapeutics use?

Minus sign iconPlus sign icon
Code Biotherapeutics's tech stack includes Google Analytics Enhanced eCommerceWixCart FunctionalityMicrosoft PowerPointGoogle CloudLodashreCAPTCHAMinitab.

What is Code Biotherapeutics's email format?

Minus sign iconPlus sign icon
Code Biotherapeutics's email format typically follows the pattern of . Find more Code Biotherapeutics email formats with LeadIQ.

How much funding has Code Biotherapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, Code Biotherapeutics has raised $75M in funding. The last funding round occurred on Jun 07, 2022 for $75M.

When was Code Biotherapeutics founded?

Minus sign iconPlus sign icon
Code Biotherapeutics was founded in 2020.
Code Biotherapeutics

Code Biotherapeutics

Biotechnology ResearchPennsylvania, United States11-50 Employees

Code Bio was founded on the belief that more can be done for people living with debilitating genetic diseases. We are driven by the potential of our transformative technology to deliver precision genetic medicines for patients.

Code Bio leverages its proprietary, novel, multivalent, synthetic DNA delivery platform, 3DNA®, which has been engineered to overcome many of the challenges inherent with delivery of genetic medicines, such as: dose related toxicity, off-target effects, immunogenicity, gene size and delivery limitations, bioavailability, ability to re-dose, and vector manufacturing complexity.

The Company is advancing an internal pipeline focusing on a variety of diseases with its most advanced research in Duchenne’s Muscular Dystrophy (DMD). Code Bio also has research programs underway based on targeting data focused on the lungs, pancreas, and liver.

Section iconCompany Overview

Headquarters
2801 Sterling Dr Hatfield, Pennsylvania 19440 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    Code Biotherapeutics has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $75M.

  • $10M

    Code Biotherapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $75M

    Code Biotherapeutics has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $75M.

  • $10M

    Code Biotherapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.